# Levation Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/levation-pharma

- Industry: Pharmaceuticals
- Headquarters: Tel Aviv-Yafo, Israel
- Website: www.levationpharma.com/
- Latest round: Series B (Jun 28, 2022)
- Investors on record: 1

## About

Based in Tel Aviv, Israel, and founded in 2017 by Houman Hemmati, Levation Pharma, Ltd. operates as a healthcare company that develops therapies for aesthetic and functional eyelid and facial conditions. Levation Pharma, Ltd. raised venture funding from investor Peregrine Ventures.

The firm offers therapies for treating Acquired Blepharoptosis, a condition causing drooping of the upper eyelids. The company’s product line includes medicines for aesthetic dermatology such as the LEV-102, an aqueous gel designed for daily application to the upper eyelids. LEV-102 contains oxymetazoline, which targets Mueller’s muscle to lift the upper lid and improve visual fields and appearance without affecting voluntary eye muscles.

## Funding rounds

- Series B, Jun 28, 2022 — Peregrine Ventures

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Series B